5-(4-Chlorobutyl)-1-Cyclohexyl-1H-Tetrazole

Home 5-(4-Chlorobutyl)-1-Cyclohexyl-1H-Tetrazole
CAS No. 73963-42-5 | Cilostazol Key Intermediate

5-(4-Chlorobutyl)-1-Cyclohexyl-1H-Tetrazole

The substance named 5-(4-Chlorobutyl)-1-Cyclohexyl-1H-Tetrazole represents one more specialty intermediate provided by Alex Pharmachem, and it has certain distinctive features compared to the other intermediates presented in the company’s offer due to its crucial part played in drug production. The intermediate described above serves as a very important element in Cilostazol production, which has been proved to be an effective antiplatelet agent used for treating intermittent claudication linked to peripheral arterial disease.

One should pay attention to the fact that the tetrazole ring, which is the core of the described substance, can be achieved only by means of strictly regulated reaction, and proper placement of cyclohexyl and chlorobutyl groups is essential for obtaining desirable characteristics of the final product. It is this discipline in production processes that makes Alex Pharmachem a reliable supplier of high-quality compounds for research purposes and industry applications.

Taking into account the fact that the mentioned intermediate plays a key role in the production of Cilostazol, it will be highly beneficial for pharmaceutical companies developing cardiovascular and antiplatelet drugs.

5-(4-Chlorobutyl)-1-Cyclohexyl-1H-Tetrazole Manufacturer - Alex Pharmachem
Cilostazol Key Intermediate
CAS No. 73963-42-5 | High Purity Grade

Key Features

Cilostazol Synthesis Intermediate
High Purity & Structural Consistency
Reliable Batch-to-Batch Quality
Suitable for Research & Industrial Scale
Competitive Pricing & Prompt Supply

Key Applications

01
Cilostazol (Antiplatelet) Manufacturing
02
Cardiovascular Drug Research
03
Pharmaceutical Process Chemistry
04
Analytical & Reference Standard Use
05
Industrial Organic Synthesis

Export Markets

This intermediate is supplied as part of Alex Pharmachem's specialty chemicals portfolio, reaching pharmaceutical manufacturers and research institutions within the company's broader international network.

Frequently Asked Questions

It's used as a key intermediate in the synthesis of Cilostazol, an antiplatelet medication prescribed for peripheral arterial disease.

No, it's a synthesis intermediate, not a finished pharmaceutical product.

Pharmaceutical manufacturers and research labs involved in cardiovascular drug development and process chemistry.

Yes, it's available for export as part of the company's specialty intermediates range.